These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 19437335

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
    Goto S, Tamura N, Sakakibara M, Ikeda Y, Handa S.
    Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
    [Abstract] [Full Text] [Related]

  • 3. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH, Schmidt EB, Maurer-Spurej E, Kristensen SR.
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [Abstract] [Full Text] [Related]

  • 4. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T, Nishikawa M, Tanigawa T, Okinaka T, Wada H, Shiku H, Ikeda Y, Ito M, Isaka N, Nakano T.
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [Abstract] [Full Text] [Related]

  • 5. The effect of antiplatelet drugs clopidogrel and aspirin is less immediately after stent implantation.
    Siller-Matula JM, Haberl K, Prillinger K, Panzer S, Lang I, Jilma B.
    Thromb Res; 2009 Apr; 123(6):874-80. PubMed ID: 19135705
    [Abstract] [Full Text] [Related]

  • 6. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
    van Werkum JW, Topcu Y, Postma S, Kelder JC, Hackeng CM, ten Berg JM, Verheugt FW.
    Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
    [No Abstract] [Full Text] [Related]

  • 7. Prevalence of unresponsiveness to aspirin and/or clopidogrel in patients with stable coronary heart disease.
    Lordkipanidzé M, Diodati JG, Schampaert E, Palisaitis DA, Pharand C.
    Am J Cardiol; 2009 Nov 01; 104(9):1189-93. PubMed ID: 19840560
    [Abstract] [Full Text] [Related]

  • 8. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study.
    Velik-Salchner C, Maier S, Innerhofer P, Streif W, Klingler A, Kolbitsch C, Fries D.
    Anesth Analg; 2008 Dec 01; 107(6):1798-806. PubMed ID: 19020120
    [Abstract] [Full Text] [Related]

  • 9. Cross validation of the Multiple Electrode Aggregometry. A prospective trial in healthy volunteers.
    Siller-Matula JM, Gouya G, Wolzt M, Jilma B.
    Thromb Haemost; 2009 Aug 01; 102(2):397-403. PubMed ID: 19652892
    [Abstract] [Full Text] [Related]

  • 10. Platelet response to aspirin and clopidogrel in patients with peripheral atherosclerosis.
    Madsen EH, Gehr NR, Johannesen NL, Schmidt EB, Kristensen SR.
    Platelets; 2011 Aug 01; 22(7):537-46. PubMed ID: 21591982
    [Abstract] [Full Text] [Related]

  • 11. Clopidogrel but not Aspirin prevents acute smoking-induced platelet aggregation in patients with stable coronary artery disease.
    Addad F, Chakroune T, Asma A, Abderazek F, Zohra D, Ghrissi I, Hassine M, Gamra H, Elalamy I.
    Thromb Res; 2009 Feb 01; 123(4):640-3. PubMed ID: 18602138
    [No Abstract] [Full Text] [Related]

  • 12. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin.
    Fox SC, May JA, Shah A, Neubert U, Heptinstall S.
    Platelets; 2009 Jun 01; 20(4):250-9. PubMed ID: 19440925
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease.
    Kim H, Lee HK, Han K, Jeon HK.
    Ann Clin Lab Sci; 2009 Jun 01; 39(3):289-94. PubMed ID: 19667414
    [Abstract] [Full Text] [Related]

  • 14. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).
    Dyszkiewicz-Korpanty A, Olteanu H, Frenkel EP, Sarode R.
    Platelets; 2007 Nov 01; 18(7):491-6. PubMed ID: 17852774
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients.
    Kotzailias N, Elwischger K, Sycha T, Rinner W, Quehenberger P, Auff E, Müller C.
    J Stroke Cerebrovasc Dis; 2007 Nov 01; 16(5):199-202. PubMed ID: 17845916
    [Abstract] [Full Text] [Related]

  • 17. An anti-von Willebrand factor aptamer reduces platelet adhesion among patients receiving aspirin and clopidogrel in an ex vivo shear-induced arterial thrombosis.
    Arzamendi D, Dandachli F, Théorêt JF, Ducrocq G, Chan M, Mourad W, Gilbert JC, Schaub RG, Tanguay JF, Merhi Y.
    Clin Appl Thromb Hemost; 2011 Nov 01; 17(6):E70-8. PubMed ID: 21078615
    [Abstract] [Full Text] [Related]

  • 18. Aspirin and clopidogrel resistance-a myth or reality: an update.
    Gupta S, Gupta MM.
    Indian Heart J; 2008 Nov 01; 60(3):245-53. PubMed ID: 19240315
    [No Abstract] [Full Text] [Related]

  • 19. Enhanced platelet activation by prolactin in patients with ischemic stroke.
    Wallaschofski H, Lohmann T, Hild E, Kobsar A, Siegemund A, Spilcke-Liss E, Hentschel B, Stumpf C, Daniel WG, Garlichs CD, Eigenthaler M.
    Thromb Haemost; 2006 Jul 01; 96(1):38-44. PubMed ID: 16807649
    [Abstract] [Full Text] [Related]

  • 20. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO, Fitzgerald DJ.
    Circulation; 2007 Apr 24; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.